Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

被引：0
|
作者：
K. H. Chan
R. L. O’Connell
D. R. Sullivan
L. S. Hoffmann
K. Rajamani
M. Whiting
M. W. Donoghoe
M. Vanhala
A. Hamer
B. Yu
R. Stocker
M. K. C. Ng
A. C. Keech
机构：
[1] Royal Prince Alfred Hospital,Department of Cardiology
[2] Sydney Medical School,National Health and Medical Research Council Clinical Trials Centre, Level 6, Medical Foundation Building, K25
[3] The Heart Research Institute,Department of Biochemistry
[4] University of Sydney,Center for Vascular Research, School of Medical Sciences (Pathology) and Bosch Institute
[5] Royal Prince Alfred Hospital,Department of Medical Biochemistry
[6] University of Sydney,Unit of Family Practice
[7] Flinders Medical Centre,Department of Cardiology
[8] Central Finland Central Hospital,Department of Molecular and Clinical Genetics
[9] Nelson Hospital,undefined
[10] Royal Prince Alfred Hospital,undefined
来源：
Diabetologia | 2013年 / 56卷
关键词：
Amputation; Bilirubin; Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study; Peripheral arterial disease; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：724 / 736
页数：12
相关论文
共 50 条
  • [1] Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
    Chan, K. H.
    O'Connell, R. L.
    Sullivan, D. R.
    Hoffmann, L. S.
    Rajamani, K.
    Whiting, M.
    Donoghoe, M. W.
    Vanhala, M.
    Hamer, A.
    Yu, B.
    Stocker, R.
    Ng, M. K. C.
    Keech, A. C.
    DIABETOLOGIA, 2013, 56 (04) : 724 - 736
  • [2] Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
    Davis, T. M. E.
    Ting, R.
    Best, J. D.
    Donoghoe, M. W.
    Drury, P. L.
    Sullivan, D. R.
    Jenkins, A. J.
    O'Connell, R. L.
    Whiting, M. J.
    Glasziou, P. P.
    Simes, R. J.
    Kesaniemi, Y. A.
    Gebski, V. J.
    Scott, R. S.
    Keech, A. C.
    DIABETOLOGIA, 2011, 54 (02) : 280 - 290
  • [3] Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
    T. M. E. Davis
    R. Ting
    J. D. Best
    M. W. Donoghoe
    P. L. Drury
    D. R. Sullivan
    A. J. Jenkins
    R. L. O’Connell
    M. J. Whiting
    P. P. Glasziou
    R. J. Simes
    Y. A. Kesäniemi
    V. J. Gebski
    R. S. Scott
    A. C. Keech
    Diabetologia, 2011, 54 : 280 - 290
  • [4] Risk predictors of lower-limb amputation in patients with type 2 diabetes mellitus in the fenofibrate intervention and event lowering in diabetes study
    Rajamani, J. K.
    Li, L.
    Best, J. D.
    Voysey, M.
    Ting, R.
    d'Emden, M. C.
    Laakso, M.
    Baker, J. R.
    Keech, A. C.
    DIABETOLOGIA, 2011, 54 : S469 - S470
  • [5] Fenofibrate Reduces Peripheral Neuropathy in Type 2 Diabetes: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
    Rajamani, Kushwin
    Donoghoe, Mark
    Li, Liping
    Ting, Ru-Dee
    Colman, Peter G.
    Drury, Paul
    Laakso, Markku
    Keech, Anthony C.
    CIRCULATION, 2010, 122 (21)
  • [6] FENOFIBRATE REDUCES PERIPHERAL NEUROPATHY IN TYPE 2 DIABETES: THE FENOFIBRATE INTERVENTION AND EVENT LOWERING IN DIABETES (FIELD) STUDY
    Rajamani, K.
    Donoghoe, M.
    Li, L.
    Ting, R. -D.
    Colman, P.
    Scott, R.
    Laakso, M.
    Keech, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 219 - 220
  • [7] Fenofibrate intervention and event lowering in diabetes: the field study
    Keech, A
    ATHEROSCLEROSIS, 1998, 136 : S34 - S34
  • [8] Effect of Fenofibrate on Cardiovascular Events and Mortality in Women with Type 2 Diabetes: Results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
    D'Emden, Michael
    Li, Ping Li
    Zannino, Diana
    Best, James
    Keech, Anthony C.
    DIABETES, 2009, 58 : A178 - A178
  • [9] Effects of fenofibrate on silent myocardial infarction, hospitalization for acute coronary syndromes and amputation in type 2 diabetes: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
    Burgess, David
    Hunt, David
    Li, LiPing
    Zhang, Jun
    Sy, Ray
    Laakso, Markku
    Davis, Tim
    Colman, Peter
    Forder, Peta
    Williamson, Elizabeth
    Pike, Rhana
    Keech, Anthony
    CIRCULATION, 2007, 116 (16) : 838 - 838
  • [10] Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
    Williams, K. H.
    Sullivan, D. R.
    Veillard, A. S.
    O'Brien, R.
    George, J.
    Jenkins, A. J.
    Young, S.
    Ehnholm, C.
    Duffield, A.
    Twigg, S. M.
    Keech, A. C.
    DIABETIC MEDICINE, 2016, 33 (03) : 356 - 364
12345